Human neuroendocrine tumor cell lines as a three-dimensional model for the study of human neuroendocrine tumor therapy
- PMID: 22929519
- PMCID: PMC3486771
- DOI: 10.3791/4218
Human neuroendocrine tumor cell lines as a three-dimensional model for the study of human neuroendocrine tumor therapy
Abstract
Neuroendocrine tumors (NETs) are rare tumors, with an incidence of two per 100, 000 individuals per year, and they account for 0.5% of all human malignancies. Other than surgery for the minority of patients who present with localized disease, there is little or no survival benefit of systemic therapy. Therefore, there is a great need to better understand the biology of NETs, and in particular define new therapeutic targets for patients with nonresectable or metastatic neuroendocrine tumors. 3D cell culture is becoming a popular method for drug screening due to its relevance in modeling the in vivo tumor tissue organization and microenvironment. The 3D multicellular spheroids could provide valuable information in a more timely and less expensive manner than directly proceeding from 2D cell culture experiments to animal (murine) models. To facilitate the discovery of new therapeutics for NET patients, we have developed an in vitro 3D multicellular spheroids model using the human NET cell lines. The NET cells are plated in a non-adhesive agarose-coated 24-well plate and incubated under physiological conditions (5% CO2, 37 °C) with a very slow agitation for 16-24 hr after plating. The cells form multicellular spheroids starting on the 3(rd) or 4(th) day. The spheroids become more spherical by the 6(th) day, at which point the drug treatments are initiated. The efficacy of the drug treatments on the NET spheroids is monitored based on the morphology, shape and size of the spheroids with a phase-contrast light microscope. The size of the spheroids is estimated automatically using a custom-developed MATLAB program based on an active contour algorithm. Further, we demonstrate a simple method to process the HistoGel embedding on these 3D spheroids, allowing the use of standard histological and immunohistochemical techniques. This is the first report on generating 3D spheroids using NET cell lines to examine the effect of therapeutic drugs. We have also performed histology on these 3D spheroids, and displayed an example of a single drug's effect on growth and proliferation of the NET spheroids. Our results support that the NET spheroids are valuable for further studies of NET biology and drug development.
Similar articles
-
Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors.Endocr Relat Cancer. 2019 Jun;26(6):585-599. doi: 10.1530/ERC-19-0086. Endocr Relat Cancer. 2019. PMID: 30939452
-
Development of 3D-iNET ORION: a novel, pre-clinical, three-dimensional in vitro cell model for modeling human metastatic neuroendocrine tumor of the pancreas.Hum Cell. 2024 Sep;37(5):1593-1601. doi: 10.1007/s13577-024-01113-7. Epub 2024 Aug 5. Hum Cell. 2024. PMID: 39103560 Free PMC article.
-
Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.Cytometry A. 2017 Sep;91(9):883-892. doi: 10.1002/cyto.a.23143. Epub 2017 Jun 15. Cytometry A. 2017. PMID: 28618188
-
3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs.Biotechnol Bioeng. 2019 Jan;116(1):206-226. doi: 10.1002/bit.26845. Epub 2018 Oct 27. Biotechnol Bioeng. 2019. PMID: 30367820 Review.
-
Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies.Curr Clin Pharmacol. 2015;10(4):305-10. doi: 10.2174/1574884710666151020100211. Curr Clin Pharmacol. 2015. PMID: 26548907 Review.
Cited by
-
Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line.Front Endocrinol (Lausanne). 2019 Oct 4;10:682. doi: 10.3389/fendo.2019.00682. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31636608 Free PMC article.
-
A novel pancreatic tumour and stellate cell 3D co-culture spheroid model.BMC Cancer. 2020 May 27;20(1):475. doi: 10.1186/s12885-020-06867-5. BMC Cancer. 2020. PMID: 32460715 Free PMC article.
-
The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors.Cell Death Dis. 2014 Oct 9;5(10):e1450. doi: 10.1038/cddis.2014.396. Cell Death Dis. 2014. PMID: 25299775 Free PMC article.
-
Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions.Cancers (Basel). 2023 Jul 25;15(15):3756. doi: 10.3390/cancers15153756. Cancers (Basel). 2023. PMID: 37568572 Free PMC article. Review.
-
Two well-differentiated pancreatic neuroendocrine tumor mouse models.Cell Death Differ. 2020 Jan;27(1):269-283. doi: 10.1038/s41418-019-0355-0. Epub 2019 Jun 3. Cell Death Differ. 2020. PMID: 31160716 Free PMC article.
References
-
- Taal BG, Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrinology. 2004;80:3–7. - PubMed
-
- Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroid-based drug screen: considerations and practical approach. Nat. Protocol. 2009;4:309–324. - PubMed
-
- Chan TF, Vese LA. Active contours without edges. IEEE Trans Image Process. 2001;10:266–277. - PubMed
-
- Olert J, Wiedorn KH, Goldmann T, Kühl H, Mehraein Y, Scherthan H, Niketeghad F, Vollmer E, Müller AM, Müller-Navia J. HOPE Fixation: A Novel Fixing Method and Paraffin-embedding Technique for Human Soft Tissues. Pathology-Research and Practice. 2001;197:823–826. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous